131030 Stock Chart & Stats
₩5150.00
-₩230.00(-4.28%)
―
--
Day’s Range― - ―
52-Week Range₩5,100.00 - ₩20,750.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)159.94K
Market Cap
₩90.32B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.4
Beta0.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,646,590
10 Day Avg. Volume259,096
30 Day Avg. Volume159,935
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
131030 FAQ
What was OPTUS Pharmaceutical Co. Ltd.’s price range in the past 12 months?
OPTUS Pharmaceutical Co. Ltd. lowest stock price was ₩5100.00 and its highest was ₩20750.00 in the past 12 months.
What is OPTUS Pharmaceutical Co. Ltd.’s market cap?
OPTUS Pharmaceutical Co. Ltd.’s market cap is ₩90.32B.
When is OPTUS Pharmaceutical Co. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OPTUS Pharmaceutical Co. Ltd.’s earnings last quarter?
OPTUS Pharmaceutical Co. Ltd. released its earnings results on May 15, 2026. The company reported ₩149.518 earnings per share for the quarter, beating the consensus estimate of N/A by ₩149.518.
Is OPTUS Pharmaceutical Co. Ltd. overvalued?
According to Wall Street analysts OPTUS Pharmaceutical Co. Ltd.’s price is currently Undervalued.
Does OPTUS Pharmaceutical Co. Ltd. pay dividends?
OPTUS Pharmaceutical Co. Ltd. does not currently pay dividends.
What is OPTUS Pharmaceutical Co. Ltd.’s EPS estimate?
OPTUS Pharmaceutical Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OPTUS Pharmaceutical Co. Ltd. have?
OPTUS Pharmaceutical Co. Ltd. has 17,646,590 shares outstanding.
What happened to OPTUS Pharmaceutical Co. Ltd.’s price movement after its last earnings report?
OPTUS Pharmaceutical Co. Ltd. reported an EPS of ₩149.518 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -4.203%.
Which hedge fund is a major shareholder of OPTUS Pharmaceutical Co. Ltd.?
Currently, no hedge funds are holding shares in KR:131030
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JEIL PHARMA HOLDINGS INC.
―
DongKoo Bio & Pharm Co. Ltd.
―
MedPacto, Inc.
―
Vaxcell-Bio Therapeutics
―
WITHUS PHARMACEUTICAL Co., Ltd.
―